United States · FDA National Drug Code directory
VAQTA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0006-4841_287d69ba-8eec-4e38-b787-ce9ddfb0e172
- Product NDC
- 0006-4841
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- hepatitis A vaccine, inactivated
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 19960329
- Source listing expiry
- 20261231
Source-listed ingredients
- HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED) — 50 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4841-00) / 1 mL in 1 VIAL, SINGLE-DOSE (0006-4841-01) · 0006-4841-00
- 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4841-41) / 1 mL in 1 VIAL, SINGLE-DOSE (0006-4841-01) · 0006-4841-41
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →